(Q42084127)

English

Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans

scientific article published on March 1993

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans (English)

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M Ohtawa

1

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

F Takayama

2

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

K Saitoh

3

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

T Yoshinaga

4

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

M Nakashima

5

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

language of work or name

0 references

publication date

1 March 1993

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

35

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

3

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

290-297

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

Identification of angiotensin II receptor subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381577

30 May 2018

Nonpeptide angiotensin II receptor antagonists.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381577

30 May 2018

Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381577

30 May 2018

Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381577

30 May 2018

Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of pressor response to exogenous angiotensin I and II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381577

30 May 2018

An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381577

30 May 2018

Synthesis and pharmacology of a noncompetitive antagonist of angiotensin-induced contractions of vascular smooth muscle. [Sarcosyl]1-[cysteinyl (s-methyl)]8-angiotensin II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381577

17 August 2018

Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1381577

17 August 2018

Highly sensitive microassay for aldosterone in unextracted plasma: comparison with two other methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/8471405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II measurement with high-affinity monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/8471405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/8471405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[3H]DUP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype

1 reference

https://pubmed.ncbi.nlm.nih.gov/8471405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-response relationships following oral administration of DuP 753 to normal humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/8471405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent

1 reference

https://pubmed.ncbi.nlm.nih.gov/8471405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.1993.TB05696.X

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42084127&oldid=1933493860"